Afatinib Dimaleate Intermediate CAS 314771-76-1 Purity>99.0% (HPLC) Factory

Apejuwe kukuru:

Orukọ Kemikali: (S) -N4- (3-Chloro-4-Fluorophenyl) -7-( (Tetrahydrofuran-3-yl) oxy) quinazoline-4,6-Diamine

CAS: 314771-76-1

Mimọ:> 99.0% (HPLC)

Irisi: Imọlẹ Yellow to Yellow Powder

Agbedemeji ti Afatinib Dimaleate (CAS: 850140-73-7)

E-Mail: alvin@ruifuchem.com


Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Kemikali Properties:

Orukọ Kemikali (S) -N4- (3-Chloro-4-Fluorophenyl) -7- ((Tetrahydrofuran-3-yl) oxy) quinazoline-4,6-Diamine
Awọn itumọ ọrọ sisọ N4- (3-Chloro-4-Fluorophenyl) -7-[[(3S) -Tetrahydro-3-Furanyl] oxy] -4,6-Quinazolinediamine;Afatinib Aimọ́ B;Afatinib-des (4-Dimethylamino-2-en-1-oxo)butyl;Des (4-Dimethylamino-2-en-1-oxo)butyl Afatinib
Nọmba CAS 314771-76-1
NỌMBA CAT RF-PI2028
Iṣura Ipo Ninu Iṣura, Agbara iṣelọpọ 100MT / Ọdun
Ilana molikula C18H16ClFN4O2
Òṣuwọn Molikula 374.8
Ojuami farabale 559,0 ± 50,0 ℃
iwuwo 1,473 ± 0,060 g / cm3
Brand Ruifu Kemikali

Awọn pato:

Nkan Awọn pato
Ifarahan Ina Yellow to Yellow Powder
Idanimọ Akoko Idaduro ti tente oke akọkọ ni HPLC yẹ ki o baamu si Iwọnwọn
Mimọ / Analysis Ọna > 99.0% (HPLC)
Pipadanu lori Gbigbe <0.50%
Aloku lori Iginisonu <0.20%
Aimọ Kanṣoṣo <0.50%
Lapapọ Awọn Aimọ <1.00%
Awọn irin Heavy (gẹgẹbi Pb) ≤20ppm
Igbeyewo Standard Standard Enterprise
Lilo Agbedemeji ti Afatinib Dimaleate (CAS: 850140-73-7)

Package & Ibi ipamọ:

Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin

Awọn anfani:

1

FAQ:

Ohun elo:

(S) -N4- (3-Chloro-4-Fluorophenyl) -7- ((Tetrahydrofuran-3-yl) oxy) quinazoline-4,6-Diamine (CAS: 314771-76-1) jẹ agbedemeji ti Afatinib Dimaleate. (CAS: 850140-73-7).Afatinib jẹ agbara-iran keji ti o lagbara ati inhibitor meji ti ko ni iyipada ti olugba idagba idagbasoke ti epidermal (EGFR) ati awọn olugba idagbasoke idagbasoke ti eniyan 2 (HER2) tyrosine kinase, ti o ni idagbasoke nipasẹ Boehringer Ingelheim, Germany.O lagbara lati ṣe idiwọ iṣẹ-ṣiṣe ti tyrosine kinase ni aiṣe-padabọ nipasẹ ṣiṣe iṣesi Michael pẹlu ẹgbẹ thiol ti cysteine ​​ni ipo 797 ti EGFR.Išẹ: 1. Bi Lapatinib ati Neratinib, Afatinib jẹ amuaradagba kinase inhibitor ti o tun ṣe aiṣedeede ti o ṣe idiwọ ti o ni idaabobo ti o pọju ti eniyan 2 (Her2) ati epidermal growth factor receptor (EGFR) kinases.2. Afatinib ko ṣiṣẹ nikan ni ilodi si awọn iyipada EGFR ti a fojusi nipasẹ iran akọkọ TKIs bi erlotinib tabi gefitinib, ṣugbọn tun lodi si awọn iyipada bii T790M eyiti ko ni ifarabalẹ si awọn itọju boṣewa wọnyi.Nitori iṣẹ ṣiṣe afikun rẹ lodi si Her2, o ti wa ni iwadii fun akàn igbaya bi daradara bi EGFR miiran ati awọn aarun itọka Her2.3. Afatinib jẹ oogun kan fun itọju laini akọkọ ti awọn alaisan ti o ni awọn iru iyasọtọ ti metastatic (EGFR mutation positive) ti kii-kekere sẹẹli ẹdọfóró carcinoma (NSCLC).O ṣe bi onidalẹkun covalent ti ko le yipada ti olugba tyrosine kinases olugba idagba ifosiwewe epidermal (EGFR) ati erbB-2 (HER2).

Kọ ifiranṣẹ rẹ nibi ki o si fi si wa